Leaflet AVAXIM 160U 160 U ANTIGENICE injection suspension
Indicated for: prevention of hepatitis A
Route of administration: injectable
Substance: inactivated hepatitis A vaccine (vaccine)
ATC: J07BC02 (Antiinfectives for systemic use | Viral vaccines | Hepatitis vaccines)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine is subject to additional monitoring.
Store in the refrigerator as instructed in the leaflet.
Store protected from light.
The inactivated hepatitis A vaccine is used to prevent infection with the hepatitis A virus (HAV), which can cause acute hepatitis, an inflammatory liver disease. The vaccine contains inactivated hepatitis A viruses, which stimulate the immune system to produce specific antibodies against HAV.
The vaccine is administered intramuscularly, usually in two doses, 6-12 months apart. It is recommended for individuals traveling to endemic areas, children, food industry workers, and others at increased risk of infection.
Common side effects include pain at the injection site, mild fever, fatigue, and nausea. In rare cases, severe allergic reactions may occur.
The inactivated hepatitis A vaccine is an important preventive measure for reducing the risk of HAV infection and its associated complications, contributing to public health protection.
General data about AVAXIM 160U 160 U ANTIGENICE
- Substance: inactivated hepatitis A vaccine
- Date of latest medicines list: 01-07-2013
- Product code: W13439003
- Concentration: 160 U ANTIGENICE
- Pharmaceutical form: injection suspension
- Quantity: 10
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for inactivated hepatitis A vaccine
- 1440 U.El./ml
- 160 U ANTIGENICE
- 25 U/0.5ml
- 50 U/ml
- 720 U. Elisa